Financial Gravity Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Financial Gravity Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$14K	Buy	+185	New	+$2.87K	0.01%	848

Other funds holding ORGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

NMIMC

Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $8.53B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Financial Gravity Asset Management's ORGO Position: Q3 2021 in Review

Financial Gravity Asset Management opened a new position in Organogenesis Holdings (ORGO) in Q3 2021: 185 shares worth $14K. The stake represents 0.01% of the portfolio and ranks #848 among its holdings.

153 funds tracked by Wall St. Rank hold ORGO as of Q3 2021.

Financial Gravity Asset Management held 185 shares of Organogenesis Holdings worth $14K as of Q3 2021.
Organogenesis Holdings was a new Financial Gravity Asset Management position in Q3 2021.
Organogenesis Holdings made up 0.01% of Financial Gravity Asset Management's portfolio in Q3 2021, its #848 holding.
153 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2021.

Based on Financial Gravity Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.